APELLIS PHARMACEUTICALS
(NASDAQ: APLS)

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

27.980

+0.720 (+2.64%)
Range 27.110 - 28.100   (3.65%)
Open 27.310
Previous Close 27.260
Bid Price 82.290
Bid Volume 8
Ask Price 86.510
Ask Volume 8
Volume 1,221,967
Value -
Remark
Delayed prices. Updated at 02 Nov 2024 04:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis